Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MVT-100: Advancing the Clinical Use of Perflutren Ultrasound Contrast Agents for Suboptimal Echocardiograms

NCT03882359 is registered in ClinicalTrials.gov with Microvascular Therapeutics, LLC as lead sponsor.

NCT NCT03882359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03882359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MVT-100: Advancing the Clinical Use of Perflutren Ultrasound Contrast Agents for Suboptimal Echocardiograms
Lead sponsor
Microvascular Therapeutics, LLC
Phase
Phase 1/2
Overall status
Completed
Start date
April 25, 2019
Completion date
May 6, 2025
Enrollment
16 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

heart diseases